<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C36EE55B-5F90-4CC8-8133-9C6576DB6A0D"><gtr:id>C36EE55B-5F90-4CC8-8133-9C6576DB6A0D</gtr:id><gtr:name>Senexis Ltd Cambridge</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D60D1DAC-CEF6-40DD-BD36-75B5809C9544"><gtr:id>D60D1DAC-CEF6-40DD-BD36-75B5809C9544</gtr:id><gtr:name>C4X Discovery Ltd (formerly : Conformetrix Ltd)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/39F6E0CC-F302-4D7C-8B64-E8E4027CEE09"><gtr:id>39F6E0CC-F302-4D7C-8B64-E8E4027CEE09</gtr:id><gtr:name>Rostock University</gtr:name><gtr:address><gtr:line1>Albert-Einstein-Str.2</gtr:line1><gtr:line4>D-18051 Rostock</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FEF0A749-B120-4F09-B8E8-01CFCDFC0A2F"><gtr:id>FEF0A749-B120-4F09-B8E8-01CFCDFC0A2F</gtr:id><gtr:name>Baylor College of Medicine</gtr:name><gtr:address><gtr:line1>Baylor College of Medicine</gtr:line1><gtr:line2>Texas Medical Center</gtr:line2><gtr:line4>Houston</gtr:line4><gtr:line5>Texas</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/740620CE-EA7F-48B2-BE09-4511F7E4CE20"><gtr:id>740620CE-EA7F-48B2-BE09-4511F7E4CE20</gtr:id><gtr:name>MRC Functional Genetics Unit</gtr:name><gtr:address><gtr:line1>Department of Human Anatomy and Genetics</gtr:line1><gtr:line2>University of Oxford</gtr:line2><gtr:line3>South Parks Road</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 3QX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/740620CE-EA7F-48B2-BE09-4511F7E4CE20"><gtr:id>740620CE-EA7F-48B2-BE09-4511F7E4CE20</gtr:id><gtr:name>MRC Functional Genetics Unit</gtr:name><gtr:address><gtr:line1>Department of Human Anatomy and Genetics</gtr:line1><gtr:line2>University of Oxford</gtr:line2><gtr:line3>South Parks Road</gtr:line3><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 3QX</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C36EE55B-5F90-4CC8-8133-9C6576DB6A0D"><gtr:id>C36EE55B-5F90-4CC8-8133-9C6576DB6A0D</gtr:id><gtr:name>Senexis Ltd Cambridge</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D60D1DAC-CEF6-40DD-BD36-75B5809C9544"><gtr:id>D60D1DAC-CEF6-40DD-BD36-75B5809C9544</gtr:id><gtr:name>C4X Discovery Ltd (formerly : Conformetrix Ltd)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/39F6E0CC-F302-4D7C-8B64-E8E4027CEE09"><gtr:id>39F6E0CC-F302-4D7C-8B64-E8E4027CEE09</gtr:id><gtr:name>Rostock University</gtr:name><gtr:address><gtr:line1>Albert-Einstein-Str.2</gtr:line1><gtr:line4>D-18051 Rostock</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FEF0A749-B120-4F09-B8E8-01CFCDFC0A2F"><gtr:id>FEF0A749-B120-4F09-B8E8-01CFCDFC0A2F</gtr:id><gtr:name>Baylor College of Medicine</gtr:name><gtr:address><gtr:line1>Baylor College of Medicine</gtr:line1><gtr:line2>Texas Medical Center</gtr:line2><gtr:line4>Houston</gtr:line4><gtr:line5>Texas</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/CCCCCB82-55DE-4C4E-BBA2-CA7683EB7CA0"><gtr:id>CCCCCB82-55DE-4C4E-BBA2-CA7683EB7CA0</gtr:id><gtr:firstName>David</gtr:firstName><gtr:otherNames>Barry</gtr:otherNames><gtr:surname>Sattelle</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U137761447"><gtr:id>284F6C97-B84A-4A43-BECE-E107147FDC33</gtr:id><gtr:title>Nicotinic receptor signalling dysfunction in neurodegenerative disease</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U137761447</gtr:grantReference><gtr:abstractText>Fast chemical synaptic signalling in the brain and at nerve-muscle junctions involving the neurotransmitter acetylcholine is mediated by nicotinic receptor molecules (nAChRs). Drugs affecting brain nAChRs have the potential to ameliorate the effects of disorders such as Alzheimers disease (AD), Parkinsons disease and schizophrenia. Altered DNA sequences in nAChRs can lead directly to congenital myasthenia syndrome (CMS) and one form of epilepsy. Comparing nAChR functions and sequence from a nematode worm, C. elegans, with those of its human counterpart has yielded new insights into a hitherto poorly understood human drug binding site, thereby accelerating the prospects of generating new drugs targeting AD.||C. elegans and the fruitfly, D. melanogaster, are also being used to model important human disorders of the nervous system and the neuromuscular junction, such as Alzheimers disease, inclusion body myositis (IBM), spinal muscular atrophy and congenital myasthenia. Recently, in collaboration with Senexis Ltd, we have begun to test inhibitors of amyloid oligomerisation as new potential therapeutics for IBM. http://www.mrc.ac.uk/Newspublications/News/MRC006187||We also use C. elegans gene knockdown studies which can highlight rapidly those AD risk factors which most strongly influence amyloid-induced toxicity and help uncover new targets and pathways to which treatments could be directed.</gtr:abstractText><gtr:technicalSummary>Nicotinic acetylcholine receptors (nAChRs) play a key role in cholinergic synaptic transmission in the brain and at nerve-muscle junctions. Disorders associated with nAChRs studied by the Sattelle group include Alzheimers disease (AD), Rasmussens encephalitis and congenital myasthenia syndrome (CMS). The nAChR molecules are assembled from a family of subunits and the many subtypes offer drug targets for AD, CMS and other disorders, e.g. epilepsy, schizophrenia and Parkinsons disease. Our experimental approaches, which range from the study of single genes through to behaviour, provide multiple points of entry for analysis, new leads for therapy and opportunities for translational medicine.||Genomes of the worm and fly, the first animal genomes to be sequenced, are accelerating progress in understanding the molecular basis of neural signalling. The largest and most diverse nAChR gene family known is under investigation in C. elegans. Mutants of particular interest include the x26 allele of the nAChR unc-63 gene, with a missense C151Y mutation that opens up the extracellular dicysteine loop, providing a new animal model for one form of Fast Channel CMS. We have now developed a model for Slow Channel CMS and, importantly, automated phenotyping, which greatly accelerates drug screening in these simple, low-cost, oral delivery disease models. Invertebrate models of AD, CMS, inclusion body myositis, spinal muscular atrophy and muscular dystrophy have all been investigated. In collaboration with MRCT, we are testing the NINDs chemical library containing many approved drugs in attempt to explore their potential utility in meeting unmet clinical needs for rarer degenerative diseases of nerve and muscle. In a new development undertaken in collaboration with colleagues in Cardiff and Cambridge, we are using genome-scale RNA interference (RNAi) studies to leverage added value from genome-wide association studies (GWAS) on Alzheimers patients. By this means, we can identify those AD risk factors which most strongly influence amyloid-induced toxicity and we also help pinpoint new molecular targets and pathways for therapeutic intervention.||Our work has attracted Industrial collaborations from Pfizer, Senexis Ltd and Merial in the context of drug discovery as well as medical charities such as The Alzheimers Research Trust in the context of understanding Alzheimers disease risk factors.</gtr:technicalSummary><gtr:fund><gtr:end>2011-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1999-10-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1770200</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:department>Pfizer Animal Health</gtr:department><gtr:description>Pfizer collaboration on drug targets</gtr:description><gtr:id>3588D4A8-D8F5-481B-AE79-3E6ADC377165</gtr:id><gtr:impact>PLOS Pathogens PMID: 19609360</gtr:impact><gtr:outcomeId>409FC616546-1</gtr:outcomeId><gtr:partnerContribution>Research tools to understand drug binding site</gtr:partnerContribution><gtr:piContribution>Functional expression of novel cloned receptors.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Baylor College of Medicine</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Baylor College of Medicine collaborations on genome annotation</gtr:description><gtr:id>D98BC288-854C-4B22-81E1-A133AEFA5729</gtr:id><gtr:impact>2x Nature articles (PMID: 17073008; PMID: 18362917); also a Genome Res paper (PMID: 17065676. Science article now published - add in PMID no.</gtr:impact><gtr:outcomeId>ED7C1239770-1</gtr:outcomeId><gtr:partnerContribution>Annotation of related gene families and provision of sequence data facilitating our own gene family annotation and downstream functional projects.</gtr:partnerContribution><gtr:piContribution>Genome annotation with the DBS laboratory contributing to the annotation of cys-loop ligand-gated ion channel families.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>C4X Discovery Ltd (formerly : Conformetrix Ltd)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Conformetrix collaboration on drug binding sites</gtr:description><gtr:id>730E69D2-1A4B-4C6E-9B4B-1CE28FCAF5D3</gtr:id><gtr:impact>Sattelle et al (2009) PMID: 19549506
Patent is in process, and MRCT have negotiated a 5% royalty stream on any molecules successfully commercially developed.</gtr:impact><gtr:outcomeId>A9194EBDBD1-1</gtr:outcomeId><gtr:partnerContribution>Chemical tools help better define the drug binding site.</gtr:partnerContribution><gtr:piContribution>Site directed mutagenesis to better understand drug binding residues on nicotinic receptors</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Cancer and Genetics</gtr:department><gtr:description>Cambridge, Cardiff collaboration on Alzheimer's disease</gtr:description><gtr:id>747AB72F-CE0C-4F05-A2E5-EDE42CCB8E40</gtr:id><gtr:impact>Papers in press: Trends in Biochemical Sciences and Disease Models and Mechanisms accepted for publication in early 2010. 
ART grant in Cambridge continues until mid-2011, so other papers are in preparation.</gtr:impact><gtr:outcomeId>9D126694797-1</gtr:outcomeId><gtr:partnerContribution>Working with a clinician and experts on GWAS studies has been beneficial.Working with a clinician and experts on GWAS studies has been beneficial.</gtr:partnerContribution><gtr:piContribution>RNAi screening of a C. elegans model of Alzheimer's disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Genetics</gtr:department><gtr:description>Cambridge, Cardiff collaboration on Alzheimer's disease</gtr:description><gtr:id>9CBCEE03-E813-4AF9-8DE3-7C3FDB846EDA</gtr:id><gtr:impact>Papers in press: Trends in Biochemical Sciences and Disease Models and Mechanisms accepted for publication in early 2010. 
ART grant in Cambridge continues until mid-2011, so other papers are in preparation.</gtr:impact><gtr:outcomeId>9D126694797-2</gtr:outcomeId><gtr:partnerContribution>Working with a clinician and experts on GWAS studies has been beneficial.Working with a clinician and experts on GWAS studies has been beneficial.</gtr:partnerContribution><gtr:piContribution>RNAi screening of a C. elegans model of Alzheimer's disease.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Senexis Ltd Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Senexis collaboration on inhibitors of amyloid aggregation</gtr:description><gtr:id>61CB23EA-6898-4CD2-8E14-3434FE7CCB4F</gtr:id><gtr:impact>Output was a successful grant bid (output of grant described in G0801760)</gtr:impact><gtr:outcomeId>57D2127543E-1</gtr:outcomeId><gtr:partnerContribution>Novel chemistry</gtr:partnerContribution><gtr:piContribution>We developed the use of a C. elegans model for screening drugs that inhibit amyloid aggregation.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Rostock</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Neuroembryonic Research Laboratory Rostock</gtr:department><gtr:description>Rostock collaboration</gtr:description><gtr:id>734D51FF-42BD-4B62-AAEA-1CE73329C21E</gtr:id><gtr:impact>J Comp Neurol 497, 808-816. PMID:16786553
Briese et al. Human Mol genet 200918:97-104.</gtr:impact><gtr:outcomeId>C2988401595-1</gtr:outcomeId><gtr:partnerContribution>Access to unique research materials</gtr:partnerContribution><gtr:piContribution>antibody localisation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>House of Parliament SET for Britain</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>6C81D868-F88C-4532-9526-4F71AF061874</gtr:id><gtr:impact>Presentation of research findings to Members of Parliament

Won prize - gold medal award (2006) for work on the use of Drosophila to understand Alzheimer's disease</gtr:impact><gtr:outcomeId>6D6B0B71FFF</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2006,2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School visit-Oakington Cambs</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>E3F073CA-E247-4F06-9FE2-131AAF91BFDA</gtr:id><gtr:impact>Presenting to children the use of C. elegans in research

Appreciated and led to request for repeat</gtr:impact><gtr:outcomeId>EA3E57A0096</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>House of Parliament: presenting Research to MPs</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>73AC393F-0E15-4F00-BE8B-0B483C8F26BC</gtr:id><gtr:impact>Joint presentation with Cambridge colleagues on uses of model organisms (C. elegans and D. melanogaster) in understanding Alzheimer's disease

Useful 1:1 discussion with MPs on model organism research</gtr:impact><gtr:outcomeId>DD3CB1D9792</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Articles to disseminate work to broader audience in Industry</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>2C97B0CA-D867-45F7-BBE4-E9F5F972B28A</gtr:id><gtr:impact>Articles in Lab Times and Eur Pharmaceutical Review that reach a broad audience of science professionals in Industry

Inquiries from Industry re techniques developed by the lab.</gtr:impact><gtr:outcomeId>6CB8230878C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Member of International Advisory panel for the use of model organisms in studying neurodegenerative disease - UK, Germany and Canada</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>AB60B5F3-CE6D-445A-A355-BF1CD2DB7765</gtr:id><gtr:impact>First meeting of a panel of leading international experts to develop policy for tri-partite international collaboratuiion in combating neurodegenerative disease.

Process of developing strategy is ongoing</gtr:impact><gtr:outcomeId>VuEv6HxHvwo</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>26400</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Pfizer Nicotinics Grant</gtr:description><gtr:end>2008-09-02</gtr:end><gtr:fundingOrg>Pfizer Ltd</gtr:fundingOrg><gtr:id>CA12CF34-157A-4758-B4B2-26A7AC5F7FED</gtr:id><gtr:outcomeId>1F08494DDC70</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2008-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>45932</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ART Grant - Using worms and flies to screen human genes associated with Alzheimer's Disease.</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>24A96A2C-6979-48C8-9CF7-F12412093ADA</gtr:id><gtr:outcomeId>2F799D74DAC0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>105345</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Merial Plc</gtr:department><gtr:description>Merial Research Grant - Invertebrate Ionotropic Receptors</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>Sanofi</gtr:fundingOrg><gtr:id>6213E42B-0CEE-4902-AE73-A3C51FDDCFAA</gtr:id><gtr:outcomeId>AFC5906B55B0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2009-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>122150</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Neuroscience DPhil studentship</gtr:description><gtr:end>2007-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>74DFF2F0-85F0-48DE-AF62-BB092C9AFD2C</gtr:id><gtr:outcomeId>8F8A54EFAE50</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>26016</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>IBRO John G Nicholls Postdoctoral Research fellowship</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>International Brain Research Organisation (IBRO)</gtr:fundingOrg><gtr:id>5582B433-35A0-4216-BA8B-AD5119BE7164</gtr:id><gtr:outcomeId>B07ACC872EE0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>International Advisory panel for the use of model organisms in studying neurodegenerative disease - UK, Germany and Canada</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>3CE3C458-5B2E-4F32-A5B6-381DB2909A2A</gtr:id><gtr:impact>Process of developing strategy is ongoing</gtr:impact><gtr:outcomeId>gVvJcgeg3SV</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Ministerial Summit on Dementia Research</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>C375F36B-14AB-4653-A294-56F103E5CC43</gtr:id><gtr:impact>Proioritiseing areas for research investment and co-ordination of research endeavours</gtr:impact><gtr:outcomeId>CE31ECAC557</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E138571C-C6B6-46CA-AB50-36613195EEDF</gtr:id><gtr:title>The Caenorhabditis elegans lev-8 gene encodes a novel type of nicotinic acetylcholine receptor alpha subunit.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aeaf036b5660e23ffc91057604ee4cf3"><gtr:id>aeaf036b5660e23ffc91057604ee4cf3</gtr:id><gtr:otherNames>Towers PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>pm_15088_18_15773900</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6E03FBC-2D44-4A1C-AC04-CBCC7C684114</gtr:id><gtr:title>Xenopus laevis RIC-3 enhances the functional expression of the C. elegans homomeric nicotinic receptor, ACR-16, in Xenopus oocytes.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aacbbfa58db3e346a3ae3e01d29e6b15"><gtr:id>aacbbfa58db3e346a3ae3e01d29e6b15</gtr:id><gtr:otherNames>Bennett HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>pm_15088_28_22970690</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D8390E6-AFE3-4743-8ABA-F0DA38F24EEA</gtr:id><gtr:title>Alpha7-acetylcholine receptor antibodies in two patients with Rasmussen encephalitis.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b129def860af32798ebfc1f9871af800"><gtr:id>b129def860af32798ebfc1f9871af800</gtr:id><gtr:otherNames>Watson R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>pm_15088_18_16344526</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>036A240A-6B21-4E00-96F3-E61C15584900</gtr:id><gtr:title>Strategies for automated analysis of C. elegans locomotion.</gtr:title><gtr:parentPublicationTitle>Invertebrate neuroscience : IN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/020a06f84500a7f5e3fc661ff2d82a3a"><gtr:id>020a06f84500a7f5e3fc661ff2d82a3a</gtr:id><gtr:otherNames>Buckingham SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1354-2516</gtr:issn><gtr:outcomeId>9202F4118C6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2A029A66-8FCB-4B4B-A5A3-44C01748F671</gtr:id><gtr:title>A Drosophila melanogaster cell line (S2) facilitates post-genome functional analysis of receptors and ion channels.</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aeaf036b5660e23ffc91057604ee4cf3"><gtr:id>aeaf036b5660e23ffc91057604ee4cf3</gtr:id><gtr:otherNames>Towers PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn><gtr:outcomeId>pm_15088_18_12386938</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6D258534-C11E-4BF9-855E-23DE4DAD516B</gtr:id><gtr:title>Insights into social insects from the genome of the honeybee Apis mellifera</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3f5958480af133e068b30e80b3eb07bb"><gtr:id>3f5958480af133e068b30e80b3eb07bb</gtr:id><gtr:otherNames>Weinstock G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5a361656150b91.26780428</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F85B8C53-DA9E-4E0F-AE25-6D2D7F1636AD</gtr:id><gtr:title>Nicotinic acetylcholine receptor signalling: roles in Alzheimer's disease and amyloid neuroprotection.</gtr:title><gtr:parentPublicationTitle>Pharmacological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/020a06f84500a7f5e3fc661ff2d82a3a"><gtr:id>020a06f84500a7f5e3fc661ff2d82a3a</gtr:id><gtr:otherNames>Buckingham SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0031-6997</gtr:issn><gtr:outcomeId>AF3A0F23AA8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FB02B66-0EBB-4840-95DB-7C15711A0FD9</gtr:id><gtr:title>A role for Leu118 of loop E in agonist binding to the alpha 7 nicotinic acetylcholine receptor.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3111db8d9e4be3b2c2d2f37aa95a35cb"><gtr:id>3111db8d9e4be3b2c2d2f37aa95a35cb</gtr:id><gtr:otherNames>Amiri S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn><gtr:outcomeId>D428422ACE6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>79B5E8BD-7A3F-4C83-AF57-E5A27DB1265C</gtr:id><gtr:title>Alzheimer's disease: insights from Drosophila melanogaster models.</gtr:title><gtr:parentPublicationTitle>Trends in biochemical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba8cd4e2666db5508690fa7f0df47407"><gtr:id>ba8cd4e2666db5508690fa7f0df47407</gtr:id><gtr:otherNames>Moloney A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0968-0004</gtr:issn><gtr:outcomeId>eYBnd24Xr6J</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3333E3FB-D6FF-4353-9D1B-CDE1C206C9A5</gtr:id><gtr:title>A novel Caenorhabditis elegans allele, smn-1(cb131), mimicking a mild form of spinal muscular atrophy, provides a convenient drug screening platform highlighting new and pre-approved compounds.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2429b632bedd79bf4ea4a09b0209d4fb"><gtr:id>2429b632bedd79bf4ea4a09b0209d4fb</gtr:id><gtr:otherNames>Sleigh JN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>peBntC8xeUH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BE931F4-08BD-49EB-B86A-648C68533F51</gtr:id><gtr:title>Insect genomes: challenges and opportunities for neuroscience.</gtr:title><gtr:parentPublicationTitle>Invertebrate neuroscience : IN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae7552f48df19dcfa3a21250f946f241"><gtr:id>ae7552f48df19dcfa3a21250f946f241</gtr:id><gtr:otherNames>Sattelle DB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1354-2516</gtr:issn><gtr:outcomeId>A89928924D5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47423C6C-2B7B-4ED4-BE74-AC13D74C16CC</gtr:id><gtr:title>The Abeta1-42M35C mutated amyloid peptide Abeta1-42 and the 25-35 fragment fail to mimic the subtype-specificity of actions on recombinant human nicotinic acetylcholine receptors (alpha7, alpha4beta2, alpha3beta4).</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d16d193b181d879aea10bf03fd4416c4"><gtr:id>d16d193b181d879aea10bf03fd4416c4</gtr:id><gtr:otherNames>Pym LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>DF1993507BA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA345D32-878C-433A-BB33-C9223081E45E</gtr:id><gtr:title>Proteins interacting with nicotinic acetylcholine receptors: expanding functional and therapeutic horizons.</gtr:title><gtr:parentPublicationTitle>Trends in pharmacological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18ec769d555d38c954f09f185f200a5a"><gtr:id>18ec769d555d38c954f09f185f200a5a</gtr:id><gtr:otherNames>Jones AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0165-6147</gtr:issn><gtr:outcomeId>pgH6HsiMUZA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>454D3810-006E-4BD3-BDC8-79FC273FA420</gtr:id><gtr:title>A role for Caenorhabditis elegans in understanding the function and interactions of human disease genes.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dcb49469c949feae072c406278d20bc6"><gtr:id>dcb49469c949feae072c406278d20bc6</gtr:id><gtr:otherNames>Culetto E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2000-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_15088_18_10767309</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7A4BDEF-6F75-4DC4-A510-2EC740A3E710</gtr:id><gtr:title>Exploring the pharmacological properties of insect nicotinic acetylcholine receptors.</gtr:title><gtr:parentPublicationTitle>Trends in pharmacological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aad7d2708b0b98488450daeab0ef27a1"><gtr:id>aad7d2708b0b98488450daeab0ef27a1</gtr:id><gtr:otherNames>Thany SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0165-6147</gtr:issn><gtr:outcomeId>72F5D4A8303</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9A9E37B6-6BB8-4838-8CE5-9BC041D59C14</gtr:id><gtr:title>Edit, cut and paste in the nicotinic acetylcholine receptor gene family of Drosophila melanogaster.</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae7552f48df19dcfa3a21250f946f241"><gtr:id>ae7552f48df19dcfa3a21250f946f241</gtr:id><gtr:otherNames>Sattelle DB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn><gtr:outcomeId>pm_15088_18_15770687</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C3E08845-9932-49F1-BDB0-61CB507C6057</gtr:id><gtr:title>RNA interference: from model organisms towards therapy for neural and neuromuscular disorders.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/020a06f84500a7f5e3fc661ff2d82a3a"><gtr:id>020a06f84500a7f5e3fc661ff2d82a3a</gtr:id><gtr:otherNames>Buckingham SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_15088_18_15358735</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>055CA140-2F7B-4D07-ADD8-B14402A19586</gtr:id><gtr:title>Chemistry-to-gene screens in Caenorhabditis elegans.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Drug discovery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18ec769d555d38c954f09f185f200a5a"><gtr:id>18ec769d555d38c954f09f185f200a5a</gtr:id><gtr:otherNames>Jones AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1474-1776</gtr:issn><gtr:outcomeId>pm_15088_18_15803195</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4725562B-5573-4C33-A5DE-D6DA515B0D71</gtr:id><gtr:title>The nicotinic acetylcholine receptor gene family of the pufferfish, Fugu rubripes.</gtr:title><gtr:parentPublicationTitle>Genomics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18ec769d555d38c954f09f185f200a5a"><gtr:id>18ec769d555d38c954f09f185f200a5a</gtr:id><gtr:otherNames>Jones AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2003-01-01</gtr:date><gtr:issn>0888-7543</gtr:issn><gtr:outcomeId>pm_15088_18_13679024</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24C3D055-4EB9-4B13-B5F7-19EB51734EE3</gtr:id><gtr:title>Novel alpha7-like nicotinic acetylcholine receptor subunits in the nematode Caenorhabditis elegans.</gtr:title><gtr:parentPublicationTitle>Protein science : a publication of the Protein Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f939e1125f733f93d5b2d4697ba709a"><gtr:id>1f939e1125f733f93d5b2d4697ba709a</gtr:id><gtr:otherNames>Mongan NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0961-8368</gtr:issn><gtr:outcomeId>pm_15088_18_11967372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1E48AD4-7279-4D90-AE24-FF664E4661BC</gtr:id><gtr:title>Actions of snake neurotoxins on an insect nicotinic cholinergic synapse.</gtr:title><gtr:parentPublicationTitle>Invertebrate neuroscience : IN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1da41c13446d75cb16c6570cff77fa53"><gtr:id>1da41c13446d75cb16c6570cff77fa53</gtr:id><gtr:otherNames>Hue B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1354-2516</gtr:issn><gtr:outcomeId>0AACFAEA4FE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8907AB26-0D0A-46B3-919B-052DCA80033B</gtr:id><gtr:title>A Cys-loop mutation in the Caenorhabditis elegans nicotinic receptor subunit UNC-63 impairs but does not abolish channel function.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18ec769d555d38c954f09f185f200a5a"><gtr:id>18ec769d555d38c954f09f185f200a5a</gtr:id><gtr:otherNames>Jones AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>FrZMRpqw6KW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68AB2C9F-69AB-41E6-A8B4-6D1EAB06FA18</gtr:id><gtr:title>Fast, automated measurement of nematode swimming (thrashing) without morphometry.</gtr:title><gtr:parentPublicationTitle>BMC neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/020a06f84500a7f5e3fc661ff2d82a3a"><gtr:id>020a06f84500a7f5e3fc661ff2d82a3a</gtr:id><gtr:otherNames>Buckingham SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2202</gtr:issn><gtr:outcomeId>B809CDC0FF2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E26E9E87-2D66-4B9F-B02A-C68433C81E9B</gtr:id><gtr:title>The nicotinic acetylcholine receptor gene family of the nematode Caenorhabditis elegans: an update on nomenclature.</gtr:title><gtr:parentPublicationTitle>Invertebrate neuroscience : IN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18ec769d555d38c954f09f185f200a5a"><gtr:id>18ec769d555d38c954f09f185f200a5a</gtr:id><gtr:otherNames>Jones AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1354-2516</gtr:issn><gtr:outcomeId>6AA3A62117A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B819DFF-CC59-4DFD-B596-FE1B30A917ED</gtr:id><gtr:title>An extensive and diverse gene family of nicotinic acetylcholine receptor alpha subunits in Caenorhabditis elegans.</gtr:title><gtr:parentPublicationTitle>Receptors &amp; channels</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f939e1125f733f93d5b2d4697ba709a"><gtr:id>1f939e1125f733f93d5b2d4697ba709a</gtr:id><gtr:otherNames>Mongan NP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1998-01-01</gtr:date><gtr:issn>1060-6823</gtr:issn><gtr:outcomeId>pm_15088_18_10100329</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>34A10C1B-B0EC-43B7-8002-76D24742808F</gtr:id><gtr:title>Neuronal nitric oxide synthase gene transfer decreases [Ca2+]i in cardiac sympathetic neurons.</gtr:title><gtr:parentPublicationTitle>Journal of molecular and cellular cardiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4fb28c7b7f759ed5da54d4f587d639a"><gtr:id>c4fb28c7b7f759ed5da54d4f587d639a</gtr:id><gtr:otherNames>Wang L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-2828</gtr:issn><gtr:outcomeId>E6CC7E65EC5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8B1F5FC9-D964-4C44-9EE9-3B77A8A6D790</gtr:id><gtr:title>The Caenorhabditis elegans unc-63 gene encodes a levamisole-sensitive nicotinic acetylcholine receptor alpha subunit.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dcb49469c949feae072c406278d20bc6"><gtr:id>dcb49469c949feae072c406278d20bc6</gtr:id><gtr:otherNames>Culetto E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_15088_18_15280391</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD9FC930-A3A6-4944-A9DF-C193326CA355</gtr:id><gtr:title>The cys-loop ligand-gated ion channel superfamily of the honeybee, Apis mellifera.</gtr:title><gtr:parentPublicationTitle>Invertebrate neuroscience : IN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18ec769d555d38c954f09f185f200a5a"><gtr:id>18ec769d555d38c954f09f185f200a5a</gtr:id><gtr:otherNames>Jones AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1354-2516</gtr:issn><gtr:outcomeId>57701603ADC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18A7D873-A297-41CE-9C3B-6270838DEDC6</gtr:id><gtr:title>Functional genomics: applying calcium imaging and RNA interference to Drosophila cell lines to identify new roles for gene products.</gtr:title><gtr:parentPublicationTitle>Invertebrate neuroscience : IN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/020a06f84500a7f5e3fc661ff2d82a3a"><gtr:id>020a06f84500a7f5e3fc661ff2d82a3a</gtr:id><gtr:otherNames>Buckingham SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1354-2516</gtr:issn><gtr:outcomeId>B443AD2CFC8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>37E2F6D5-F1F8-4248-9508-59F2F9909A62</gtr:id><gtr:title>A hypothesis to account for the selective and diverse actions of neonicotinoid insecticides at their molecular targets, nicotinic acetylcholine receptors: catch and release in hydrogen bond networks.</gtr:title><gtr:parentPublicationTitle>Invertebrate neuroscience : IN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c49c0a81e6625ebb579b481136ee7f5a"><gtr:id>c49c0a81e6625ebb579b481136ee7f5a</gtr:id><gtr:otherNames>Ihara M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1354-2516</gtr:issn><gtr:outcomeId>45D9F7461F9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA3D68B7-141D-476F-A2CD-EE0BFC5E7932</gtr:id><gtr:title>ShAR2beta, a divergent nicotinic acetylcholine receptor subunit from the blood fluke Schistosoma.</gtr:title><gtr:parentPublicationTitle>Parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/67481fbe72cfb9abaaa198b7e13c5292"><gtr:id>67481fbe72cfb9abaaa198b7e13c5292</gtr:id><gtr:otherNames>Bentley GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0031-1820</gtr:issn><gtr:outcomeId>827841A4296</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1ACFB55A-CD99-4952-8E88-C2ACAB575994</gtr:id><gtr:title>The cys-loop ligand-gated ion channel gene superfamily of the nematode, Caenorhabditis elegans.</gtr:title><gtr:parentPublicationTitle>Invertebrate neuroscience : IN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18ec769d555d38c954f09f185f200a5a"><gtr:id>18ec769d555d38c954f09f185f200a5a</gtr:id><gtr:otherNames>Jones AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1354-2516</gtr:issn><gtr:outcomeId>B061D97DB0B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0FCBBDF4-09BC-416C-BB5D-5ED51B8DF21B</gtr:id><gtr:title>Novel putative nicotinic acetylcholine receptor subunit genes, Dalpha5, Dalpha6 and Dalpha7, in Drosophila melanogaster identify a new and highly conserved target of adenosine deaminase acting on RNA-mediated A-to-I pre-mRNA editing.</gtr:title><gtr:parentPublicationTitle>Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a58e0976b5ee27ef4145ee33c2cb9639"><gtr:id>a58e0976b5ee27ef4145ee33c2cb9639</gtr:id><gtr:otherNames>Grauso M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>0016-6731</gtr:issn><gtr:outcomeId>pm_15088_18_11973307</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63EF1096-D41E-432A-85D9-A5EA77684D06</gtr:id><gtr:title>Amyloid peptides and ion channel function in Drosophila models of Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>SEB experimental biology series</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88a9f182b23cf87ca9c242c7d4cf809b"><gtr:id>88a9f182b23cf87ca9c242c7d4cf809b</gtr:id><gtr:otherNames>Brown LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1946-4959</gtr:issn><gtr:outcomeId>942DCDD0007</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B27431F-210D-4113-BF61-89415C3575D1</gtr:id><gtr:title>Symposium overview: mechanism of action of nicotine on neuronal acetylcholine receptors, from molecule to behavior.</gtr:title><gtr:parentPublicationTitle>Toxicological sciences : an official journal of the Society of Toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f174d49b01808da8503cb36d73c145fa"><gtr:id>f174d49b01808da8503cb36d73c145fa</gtr:id><gtr:otherNames>Narahashi T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2000-01-01</gtr:date><gtr:issn>1096-0929</gtr:issn><gtr:outcomeId>pm_15088_18_11006350</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1C36375-17CC-4A5E-9272-EC18CE30FFC4</gtr:id><gtr:title>Insights into social insects from the genome of the honeybee Apis mellifera.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9d9583ea0faedeb158a7246931960cd"><gtr:id>e9d9583ea0faedeb158a7246931960cd</gtr:id><gtr:otherNames>Honeybee Genome Sequencing Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>85EEF8D7D23</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>656C6458-C1D1-428A-9BFB-B99EA35DDEDD</gtr:id><gtr:title>Caenorhabditis elegans in the study of SMN-interacting proteins: a role for SMI-1, an orthologue of human Gemin2 and the identification of novel components of the SMN complex.</gtr:title><gtr:parentPublicationTitle>Invertebrate neuroscience : IN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a0e3a6d3f1a42ef70aeb5e205d612da"><gtr:id>7a0e3a6d3f1a42ef70aeb5e205d612da</gtr:id><gtr:otherNames>Burt EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1354-2516</gtr:issn><gtr:outcomeId>9DEC68043A5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>071CB021-85B8-4C27-B70D-23900B485540</gtr:id><gtr:title>Nicotinic acetylcholine receptors as drug/chemical targets, contributions from comparative genomics, forward and reverse genetics.</gtr:title><gtr:parentPublicationTitle>SEB experimental biology series</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae7552f48df19dcfa3a21250f946f241"><gtr:id>ae7552f48df19dcfa3a21250f946f241</gtr:id><gtr:otherNames>Sattelle DB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1946-4959</gtr:issn><gtr:outcomeId>DC3C6CCC705</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7263665D-7F39-46B4-B72A-63A7ED130428</gtr:id><gtr:title>Comparative pharmacology and computational modelling yield insights into allosteric modulation of human alpha7 nicotinic acetylcholine receptors.</gtr:title><gtr:parentPublicationTitle>Biochemical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae7552f48df19dcfa3a21250f946f241"><gtr:id>ae7552f48df19dcfa3a21250f946f241</gtr:id><gtr:otherNames>Sattelle DB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-2952</gtr:issn><gtr:outcomeId>41A5E1FA015</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D48C6825-A07D-42FB-8C52-6EB4247D538E</gtr:id><gtr:title>Cotinine reduces amyloid-? aggregation and improves memory in Alzheimer's disease mice.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11b471c5a2f70f0cd1122e916b7f6152"><gtr:id>11b471c5a2f70f0cd1122e916b7f6152</gtr:id><gtr:otherNames>Echeverria V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>pm_15088_28_21321389</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE08F17E-A4B1-41CD-9775-F78819F82C48</gtr:id><gtr:title>A7DB: a relational database for mutational, physiological and pharmacological data related to the alpha7 nicotinic acetylcholine receptor.</gtr:title><gtr:parentPublicationTitle>BMC neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/020a06f84500a7f5e3fc661ff2d82a3a"><gtr:id>020a06f84500a7f5e3fc661ff2d82a3a</gtr:id><gtr:otherNames>Buckingham SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1471-2202</gtr:issn><gtr:outcomeId>pm_15088_18_15661073</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED494E5B-60B7-4466-B354-A70FD5EE1DC6</gtr:id><gtr:title>Functional genomics of the nicotinic acetylcholine receptor gene family of the nematode, Caenorhabditis elegans.</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18ec769d555d38c954f09f185f200a5a"><gtr:id>18ec769d555d38c954f09f185f200a5a</gtr:id><gtr:otherNames>Jones AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn><gtr:outcomeId>pm_15088_18_14696039</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30911CD9-01CA-41E6-8E4B-27C25C213615</gtr:id><gtr:title>Functional genomics of ionotropic acetylcholine receptors in Caenorhabditis elegans and Drosophila melanogaster.</gtr:title><gtr:parentPublicationTitle>Novartis Foundation symposium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ae7552f48df19dcfa3a21250f946f241"><gtr:id>ae7552f48df19dcfa3a21250f946f241</gtr:id><gtr:otherNames>Sattelle DB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2002-01-01</gtr:date><gtr:issn>1528-2511</gtr:issn><gtr:outcomeId>pm_15088_18_12027012</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB16E585-D89B-4EAC-80FF-31F83519F1D8</gtr:id><gtr:title>Molecular pharmacology of insect ion channels and implications for insect toxicology.</gtr:title><gtr:parentPublicationTitle>Invertebrate neuroscience : IN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7009bbfefc9c409d00b4692f69aecd7b"><gtr:id>7009bbfefc9c409d00b4692f69aecd7b</gtr:id><gtr:otherNames>Matsuda K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1354-2516</gtr:issn><gtr:outcomeId>EA266B62564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31CFACBD-CE95-42FB-B7B3-19AED07D3DE9</gtr:id><gtr:title>Alpha7 mutants mimicking atypical motifs (YxxCC of loop-C, and E to H at -1' in TM2) in the C. elegans LEV-8 subunit affect nicotinic acetylcholine receptor function.</gtr:title><gtr:parentPublicationTitle>Invertebrate neuroscience : IN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aeaf036b5660e23ffc91057604ee4cf3"><gtr:id>aeaf036b5660e23ffc91057604ee4cf3</gtr:id><gtr:otherNames>Towers PR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1354-2516</gtr:issn><gtr:outcomeId>6F2BBA67994</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>318E582F-A8B9-4AE6-BCCF-6CEC36C8AF52</gtr:id><gtr:title>Insect nicotinic acetylcholine receptor gene families: from genetic model organism to vector, pest and beneficial species.</gtr:title><gtr:parentPublicationTitle>Invertebrate neuroscience : IN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/18ec769d555d38c954f09f185f200a5a"><gtr:id>18ec769d555d38c954f09f185f200a5a</gtr:id><gtr:otherNames>Jones AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1354-2516</gtr:issn><gtr:outcomeId>9BDEB888A2C</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U137761447</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>58</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>42</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>